The newly-emerged CRISPR prime editing technology holds tremendous promise as a highly precise editing tool for altering KRAS mutations while preserving WT KRAS functions within the targeted cancer cells without the need for double-strand breaks like the conventional CRISPR-Cas9 system [124–126]. This evidence concerns the gene KRAS and cancer.